Frédéric Baribaud

8.5k total citations · 1 hit paper
67 papers, 4.2k citations indexed

About

Frédéric Baribaud is a scholar working on Immunology, Virology and Epidemiology. According to data from OpenAlex, Frédéric Baribaud has authored 67 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Immunology, 22 papers in Virology and 12 papers in Epidemiology. Recurrent topics in Frédéric Baribaud's work include HIV Research and Treatment (22 papers), Immune Cell Function and Interaction (19 papers) and Immunotherapy and Immune Responses (18 papers). Frédéric Baribaud is often cited by papers focused on HIV Research and Treatment (22 papers), Immune Cell Function and Interaction (19 papers) and Immunotherapy and Immune Responses (18 papers). Frédéric Baribaud collaborates with scholars based in United States, United Kingdom and Germany. Frédéric Baribaud's co-authors include Robert W. Doms, Stefan Pöhlmann, George J. Leslie, James A. Hoxie, Terri G. Edwards, Graham Simmons, Paul Bates, Elizabeth J. Soilleux, Frank Mortari and George Lin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Neuroscience and The Journal of Immunology.

In The Last Decade

Frédéric Baribaud

66 papers receiving 4.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hepatitis C Virus Glycoproteins Interact with DC-SIGN and DC-SIGNR

2003 309 citations Stefan Pöhlmann, Frédéric Baribaud et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Frédéric Baribaud	1.8k	1.4k	1.2k	1.0k	831	67	4.2k
Heribert Stoiber	2.0k 1.1×	1.6k 1.1×	894 0.7×	921 0.9×	570 0.7×	119	3.6k
Jesus F. Salazar-Gonzalez	2.1k 1.2×	3.9k 2.7×	2.0k 1.6×	1.1k 1.1×	1.0k 1.2×	36	5.1k
Áine McKnight	2.4k 1.3×	2.7k 1.9×	1.2k 1.0×	701 0.7×	763 0.9×	91	4.2k
Jean‐Charles Grivel	1.9k 1.0×	1.8k 1.3×	1.0k 0.9×	1.1k 1.1×	1.2k 1.4×	108	4.5k
Gerald Nakamura	1.2k 0.7×	1.8k 1.2×	817 0.7×	880 0.9×	1.3k 1.6×	45	3.6k
Angela Granelli‐Piperno	3.8k 2.1×	1.4k 1.0×	837 0.7×	887 0.9×	1.6k 2.0×	67	7.0k
Vernon C. Maino	3.4k 1.9×	1.8k 1.2×	768 0.6×	1.3k 1.3×	962 1.2×	64	5.0k
Shoshana Marmon	2.0k 1.1×	2.4k 1.7×	1.1k 0.9×	571 0.6×	905 1.1×	25	3.7k
Guido Vanham	1.7k 0.9×	1.6k 1.1×	1.3k 1.1×	779 0.8×	946 1.1×	104	3.6k
T. C. Merigan	1.2k 0.7×	952 0.7×	1.0k 0.8×	1.1k 1.1×	473 0.6×	89	3.7k

Countries citing papers authored by Frédéric Baribaud

Since Specialization

Citations

This map shows the geographic impact of Frédéric Baribaud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frédéric Baribaud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frédéric Baribaud more than expected).

Fields of papers citing papers by Frédéric Baribaud

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frédéric Baribaud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frédéric Baribaud. The network helps show where Frédéric Baribaud may publish in the future.

Co-authorship network of co-authors of Frédéric Baribaud

This figure shows the co-authorship network connecting the top 25 collaborators of Frédéric Baribaud. A scholar is included among the top collaborators of Frédéric Baribaud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frédéric Baribaud. Frédéric Baribaud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhao, Qihong, Gary L. Schieven, Hong Qiu, et al.. (2023). POS1129 IN VITRO EVIDENCE DEMONSTRATES THAT AFIMETORAN (BMS-986256), AN EQUIPOTENT TLR7/8 DUAL ANTAGONIST, HAS STEROID-SPARING POTENTIAL IN THE CLINIC. Annals of the Rheumatic Diseases. 82. 892–892. 1 indexed citations

Finney, Lydia, Dexter Wiseman, Anthony Rowe, et al.. (2023). Using an electronic diary and wristband accelerometer to detect exacerbations and activity levels in COPD: a feasibility study. ERJ Open Research. 9(6). 366–2023. 1 indexed citations

Porter, Chad K., Mark S. Riddle, Renée M. Laird, et al.. (2020). Cohort profile of a US military population for evaluating pre-disease and disease serological biomarkers in rheumatoid and reactive arthritis: Rationale, organization, design, and baseline characteristics. Contemporary Clinical Trials Communications. 17. 100522–100522. 7 indexed citations

Pavlidis, Stelios, Calixte S. Monast, Matthew J. Loza, et al.. (2019). I_MDS: an inflammatory bowel disease molecular activity score to classify patients with differing disease-driving pathways and therapeutic response to anti-TNF treatment. PLoS Computational Biology. 15(4). e1006951–e1006951. 16 indexed citations

Baribaud, Frédéric. (2017). Molecular surrogates of histologic activity in Crohn′s disease. Journal of Cancer Science & Therapy. 2 indexed citations

Menche, Jörg, Emre Güney, Amitabh Sharma, et al.. (2017). Integrating personalized gene expression profiles into predictive disease-associated gene pools. npj Systems Biology and Applications. 3(1). 10–10. 49 indexed citations

Rosenberg, Alexander F., Yahui Grace Chiu, Rebecca Bolce, et al.. (2014). Divergent Gene Activation in Peripheral Blood and Tissues of Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis following Infliximab Therapy. PLoS ONE. 9(10). e110657–e110657. 14 indexed citations

Judson, Marc A., Richard Marchell, Elliot S. Barnathan, et al.. (2011). Molecular profiling and gene expression analysis in cutaneous sarcoidosis: The role of interleukin-12, interleukin-23, and the T-helper 17 pathway. Journal of the American Academy of Dermatology. 66(6). 901–910.e2. 58 indexed citations

Brodmerkel, Carrie, Katherine Li, Frédéric Baribaud, Mayte Suárez‐Fariñas, & James G. Krueger. (2010). Determining the extent to which clinically effective treatment, ustekinumab or etanercept, reverses the molecular disease profile of psoriatic skin: comparisons of lesional, non-lesional and normal skin (34.5). The Journal of Immunology. 184(Supplement_1). 34.5–34.5. 1 indexed citations

10.

Frobell, R., Michael C. Nevitt, M. Hudelmaier, et al.. (2010). Femorotibial subchondral bone area and regional cartilage thickness: A cross‐sectional description in healthy reference cases and various radiographic stages of osteoarthritis in 1,003 knees from the Osteoarthritis Initiative. Arthritis Care & Research. 62(11). 1612–1623. 62 indexed citations

11.

Shin, Niu, Frédéric Baribaud, Kathy Wang, et al.. (2009). Pharmacological characterization of INCB3344, a small molecule antagonist of human CCR2. Biochemical and Biophysical Research Communications. 387(2). 251–255. 21 indexed citations

12.

Lee, Jongwon, Tatiana Ort, Kai Ma, et al.. (2008). Resistin is elevated following traumatic joint injury and causes matrix degradation and release of inflammatory cytokines from articular cartilage in vitro. Osteoarthritis and Cartilage. 17(5). 613–620. 104 indexed citations

13.

Pöhlmann, Stefan, Jan Münch, Jacqueline D. Reeves, et al.. (2006). A simian immunodeficiency virus V3 loop mutant that does not efficiently use CCR5 or common alternative coreceptors is moderately attenuated in vivo. Virology. 360(2). 275–285. 3 indexed citations

14.

Krummenacher, Claude, Frédéric Baribaud, Manuel Ponce de Leon, et al.. (2004). Comparative usage of herpesvirus entry mediator A and nectin-1 by laboratory strains and clinical isolates of herpes simplex virus. Virology. 322(2). 286–299. 115 indexed citations

15.

Simmons, Graham, Jacqueline D. Reeves, Luk H. Vandenberghe, et al.. (2002). DC-SIGN and DC-SIGNR Bind Ebola Glycoproteins and Enhance Infection of Macrophages and Endothelial Cells. Virology. 305(1). 115–123. 299 indexed citations

16.

Baribaud, Frédéric, Robert W. Doms, & Stefan Pöhlmann. (2002). The role of DC-SIGN and DC-SIGNR in HIV and Ebola virus infection: can potential therapeutics block virus transmission and dissemination?. Expert Opinion on Therapeutic Targets. 6(4). 423–431. 46 indexed citations

17.

Doranz, Benjamin J., L G Filion, Francisco Díaz‐Mitoma, et al.. (2001). Safe Use of the CXCR4 Inhibitor ALX40-4C in Humans. AIDS Research and Human Retroviruses. 17(6). 475–486. 89 indexed citations

18.

Finke, Daniela, Frédéric Baribaud, Heidi Diggelmann, & Hans Acha‐Orbea. (2001). Extrafollicular Plasmablast B Cells Play a Key Role in Carrying Retroviral Infection to Peripheral Organs. The Journal of Immunology. 166(10). 6266–6275. 31 indexed citations

19.

Baribaud, Frédéric, Stefan Pöhlmann, & Robert W. Doms. (2001). The Role of DC-SIGN and DC-SIGNR in HIV and SIV Attachment, Infection, and Transmission. Virology. 286(1). 1–6. 72 indexed citations

20.

Puffer, Bridget A., Matthew Sharron, Christina Coughlan, et al.. (2000). Expression and Coreceptor Function of APJ for Primate Immunodeficiency Viruses. Virology. 276(2). 435–444. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact